It is what forwards healthcare and advances scientific endeavours.
State-of-the-Art Infrastructure
powering advanced research and innovation.
Collaborative Knowledge
enabling seamless information exchange and discovery.
Expert Research Access
connecting to specialised scientific expertise.
Breakthrough Innovations
accelerating drug development and addressing unmet medical needs.
Over Two Decades of Expertise
in Biologics.
Partnering with global innovators to enhance Biologics R&D, from optimised mAb expression systems to advanced drug delivery and toxicity testing.
Engaging with top institutes through PhD programmes and research partnerships to drive scientific advancements in Biologics.
Some scopes that the various teams at Dr. Reddy’s Biologics have explored are presented here. We truly believe that scientific collaborations are key to solving problems and, hence, are open to scientific collaboration opportunities in the space of Biosimilars.
IPDO
Business Unit
Scope
Proof-of-concept (POC) studies for antibody-drug conjugate product
Aurigene Pharmaceutical Services Ltd (APSL)
Business Unit/Subsidiaries of Dr.Reddys
Scope
Process development for new bispecific molecules
Aurigene Oncology Limited (AOL)
Business Unit/Subsidiaries of Dr.Reddys
Scope
Driving discovery of New Biological Entities (NBEs)
DRILS
Business Unit/Subsidiaries of Dr.Reddys
Scope
Scientific collaborations for mRNA POC activities
Bricks of Biologics, appreciates the contribution and celebrates our people who are the building blocks of Dr. Reddy's Biologics.
Bricks of biologics in general refers to bio-bricks as genetic building blocks which are DNA sequences that can be assembled to create complex biological systems.